Ekso Bionics (Nasdaq: EKSO), manufacturer of the Ekso Indego Personal exoskeleton, reported lower revenue numbers for its second quarter in a July 28 earnings call. “While there was abnormal weakness in the second quarter, in large part due to what we believe are short-term delays in completing some multi-device enterprise health sales, we are working…
Ekso Bionics ‘Working to Get Back on Track’ After Lower Second-Quarter Earnings Report
Ekso Bionics Q1 Earnings: Partnerships with NSM, Bionic P&O Expected to Grow Personal Health Products Segment This Year
National Seating & Mobility was announced as the exclusive CRT distributor of the Ekso Indego Personal exoskeleton in February.
New partnerships with national Complex Rehab Technology (CRT) and prosthetics/orthotics providers are expected to grow Ekso Bionics’ Personal Health Products segment for 2025, the company announced during its May 5 earnings call. Ekso Bionics (Nasdaq: EKSO) reported earnings results for the three months ending on March 31, 2025, while also commenting on what the company…